![](/s.abcnews.com/images/health/abc-chicago-04-as-170126_16x9t_240.jpg)
orchid pharma faces liquidation as lenders reject resolution plan
.1243 Used Today
318 Used Today
254 Used Today
80 Used Today
99 Used Today
Discount $10 On Your First Purchases Of $40 Or More
77 Used Today
110 Used Today
273 Used Today
323 Used Today
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). . .